Respiratory Techology

East Midlands, United Kingdom MedTech, Biotech, Medical, NHS, Pharmaceutical

Short Summary

Patented technology that delivers a precise dose of oxygen to a patient, direct to the functioning area of the lung - opening up initial contracts of £7mil+. This replaces current, ineffective methods for treating patients with respiratory failure.


  • Prototype into Intensive Care Units, demonstrating safety and performance
  • Pipeline of government contracts: £2.3m in 2021 rising to £7.2m 2022
  • Direct access to the public and private marketplace
  • Highly experienced management team and Board of Directors
  • Patents across the vertical of technologies


Previous Rounds n/a
Stage Finished Product
Investor Role Any
Please Note: Investments of this nature carry risks to your capital as well as potential rewards. Please read our Risk Warning and Disclaimer before deciding to invest.

Sign up or log in now

Sign up now to gain full access to pitches and investor profiles




You have passed the test and you may continue your with your investment.